Eli Lilly and Co is halting development of one of its experimental late-stage Alzheimer's disease treatments after preliminary results from large studies showed the drug was linked to worsening of cognition and the ability to perform daily tasks.
View full post on Yahoo! Health News

August 17th, 2010
The FLHC
Posted in
Tags:




